Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Cousillas Castiñeiras A"'
Autor:
Ana Fernández Montes, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Francisca Vázquez Rivera, Nieves Martinez Lago, Marta Covela Rúa, Antía Cousillas Castiñeiras, Paula Gonzalez Villarroel, Juan De la Cámara Gómez, José Carlos Méndez Méndez, Carmen Carriles Fernández, Manuel Sanchez Cánovas, Teresa Garcia García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good progn
Externí odkaz:
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://doaj.org/article/e00901a0b5b7464ca871c78422a4ada3
Autor:
Muñoz Martín, A., de la Cámara Gómez, J., Candamio Folgar, S., Covela, M., Ramos Vazquez, M., Costa Rivas, M., Pelegrín Mateo, F., Palomar Abril, V., Cousillas Castiñeiras, A., Guillot Morales, M., Querol Niñerola, R., Pellón Augusto, M., Pàmpols Felip, M., Coma Salvans, E., García Ferron, M., García Escobar, I., Molina, R., Colomé, E., Soria, J., Salgado, M.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Autor:
T. García, Juan de la Cámara Gómez, Alberto Carmona-Bayonas, Marta Covela Rúa, Francisca Vázquez Rivera, Paula Jiménez-Fonseca, Manuel Cánovas, Ana Montes, Carmen Carriles Fernández, Paula Gonzalez Villarroel, Nieves Martinez Lago, Antía Cousillas Castiñeiras, J. Méndez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ba7e763c6b00042f89c47722807250
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Publikováno v:
Translational Cancer Research
Gastric adenocarcinoma arises after a complex interaction between the host and environmental factors. Tumor location and TNM are the tools that currently guide treatment decisions. Surgery is the only curative treatment, but relapse is common. After
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd54482af372356169dfc20994f2ed4a
http://europepmc.org/articles/PMC8797897
http://europepmc.org/articles/PMC8797897
Autor:
Cousillas Castiñeiras, Antía
En esta tesis se analizó la relación entre el pronóstico del cáncer gástrico y biomarcadores moleculares, bioquímicos y clínicos. El diseño del estudio fue observacional, ambispectivo y multicéntrico. En la cohorte de cáncer gástrico local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1601::b5c2ecb7cf01803528f78af462d0b00c
https://hdl.handle.net/10347/29900
https://hdl.handle.net/10347/29900
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PloS one. 17(6)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeaaf1c74f10bfe501df8239567e0e09
https://pubmed.ncbi.nlm.nih.gov/35657983
https://pubmed.ncbi.nlm.nih.gov/35657983
Autor:
N. Martínez-Lago, B. Carnero Lopez, J. de la Cámara Gómez, F. Vázquez-Rivera, A. Fernández Montes, A. Cousillas Castiñeiras, N. de Dios, R. Varela Ponte, M. Reboredo-Lopez
Publikováno v:
Annals of Oncology. 33:S269-S270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbf640bf8b4a075489cd257513005874
https://doi.org/10.1016/j.annonc.2022.04.153
https://doi.org/10.1016/j.annonc.2022.04.153